Larimar Therapeutics (ZA71.STU) Q1 2026 Earnings

19MarConfirmed
Q1 2026
-0.63
-0.56
-0.49
-0.42

Details

Expected EPS
-0.42267519015
Actual EPS
-0.6305813
Surprise EPS
-0.21
Surprise Percent
+49.19%

Description

Larimar Therapeutics (ZA71.STU) has reported earnings of -0.6305813 per share for Q1 2026.

0 Comments

Share your thoughts